Metallo-organic G-quadruplex ligands in anticancer drug design

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 8, 2010, Pages 726-736

  Jiang, Y L ^a   Liu, Z P ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Anticancer drug; G quadruplexes; Ligand; Metal complexes; Stabilization; Targets; Telomeres; Telomeric DNA

Indexed keywords

3,4 TETRAMETHYLPYRIDINIUMPORPHYRAZINE; ANTINEOPLASTIC AGENT; COPPER CORROLE; COPPER TETRA N METHYL PYRIDYL PORPHYRIN; GUANINE QUADRUPLEX; MANGANESE CORROLE; NICKEL PORPHYRIN; NICKEL SALPHEN COMPLEX; PHENANTHROLINE; PLATINUM COMPLEX; PORPHYRIN COPPER; PORPHYRIN MANGANESE; TETRA N METHYL PYRIDYL PORPHYRIN; UNCLASSIFIED DRUG; ZINC PORPHYRIN; COORDINATION COMPOUND; LIGAND; PHENANTHROLINE DERIVATIVE; PYRIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG DESIGN; DRUG SELECTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; STRUCTURE ACTIVITY RELATION; CHEMISTRY; HUMAN; NEOPLASMS;

ANTINEOPLASTIC AGENTS; COORDINATION COMPLEXES; DRUG DESIGN; G-QUADRUPLEXES; HUMANS; LIGANDS; NEOPLASMS; PHENANTHROLINES; PYRIDINES;

EID: 77954710925     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710791572433     Document Type: Article

References (55)

1. Gilbert, D.E.; Feigon, J. Multistranded DNA structures. Curr. Opin. Struct. Biol., 1999, 9, 305-314.
2. Nelson, S.M.; Ferguson, L.R.; Denny, W.A. DNA and the chromosome-varied targets for chemotherapy. Cell Chromosome, 2004, 3, 2-27.
3. Han, H.; Langley, D.R.; Rangan, A.; Hurley, L.H. Selective interactions of cationic porphyrins with G-quadruplex structures. J. Am. Chem. Soc., 2001, 123, 8902-8913.
4. Lemarteleur, T.; Gomez, D.; Paterski, R.; Mandine, E.; Mailliet, P.; Riou, J.F. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. Biochem. Biophys. Res. Commun., 2004, 323, 802-808.
5. Gomez, D.; Paterski, R.; Lemarteleur, T.; Shinya, K.; Mergny, J.L.; Riou, J.F. Interaction of telomestatin with the telomeric singlestrand overhang. J. Biol. Chem., 2004, 279, 41487-41494.
6. Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; Harley, C.B.; West, M.D.; Ho, P.L.C.; Coviello, G.M.; Wright, W.E.; Weinrich, R.L; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266, 2011-2015.
7. Olaussen, K.A.; Dubrana, K.; Domont, J.; Spano, J.P.; Sabatier, L.; Soria, J.C. Telomeres and telomerase as targets for anticancer drug development. Crit. Rev. Oncol. Haematol., 2006, 57, 191-214.
8. Blasco, M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet., 2005, 6, 611-622.
9. Neidle, S.; Parkinson, G. Telomere maintenance as a target for anticancer drug discovery. Nat. Rev. Drug Discov., 2002, 1, 383-393.
10. Mergny, J.L.; Riou, J.F.; Mailliet, P.; Teulade-Fichou, M.P.; Gilson, E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res., 2002, 30, 839-865.
11. Rezler, E.M.; Bearss, D.J. Hurley, L.H. Telomeres and telomerases as drug targets. Curr. Opin. Pharmacol., 2002, 2, 415-423.
12. Reed, J.E.; Arnal, A.A.; Neidle, S.; Vilar, R. Stabilization of G-quadruplex DNA and inhibition of telomerase activity by squareplanar nickel(II) complexes. J. Am. Chem. Soc., 2006, 128, 5992-5993.
13. Reed, J.E.; Neidle, S.; Vilar, R. Stabilisation of human telomeric quadruplex DNA and inhibition of telomerase by a platinum-phenanthroline complex. Chem. Commun., 2007, 4366-4368.
14. Dixon, I.M.; Lopez, F.; Esteve, J.P.; Tejera, A.M.; Blasco, M.A.; Pratviel, G.; Meunier, B. Porphyrin derivatives for telomere binding and telomerase inhibition. ChemBioChem, 2005, 6, 123-132.
15. Bertrand, H.; Bombard, S.; Monchaud, D.; Teulade-Fichou, M.P. A platinum-quinacridine hybrid as a G-quadruplex ligand. J. Biol. Inorg. Chem., 2007, 12, 1003-1014.
16. Bertrand, H.; Monchaud, D.; De Cian, A.; Guillot, R.; Mergny, J.L.; Teulade-Fichou, M.P. The importance of metal geometry in the recognition of G-quadruplex-DNA by metal-terpyridine complexes. Org. Biomol. Chem., 2007, 5, 2555-2559.
17. Evans, S.E.; Mendez, M.A.; Turner, K.B.; Keating, L.R.; Grimes, R.T.; Melchoir, S.; Szalai, V.A. End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes. J. Biol. Inorg. Chem., 2007, 12, 1235-1249.
18. Kieltyka, R.; Fakhoury, J.; Moitessier, N.; Sleiman, H.F. Platinum phenanthroimidazole complexes as G-quadruplex DNA selective binders. Chem. Eur. J., 2008, 14, 1145-1154.
19. Monchaud, D.; Teulade-Fichou, M.P. A hitchhiker's guide to G-quadruplex ligands. Org. Biomol. Chem., 2008, 6, 627-636.
20. Ou, T.M.; Lu, Y.J.; Tan, J.H.; Huang, Z.S.; Wong, K.Y.; Gu, L.Q. G-quadruplexes: targets in anticancer drug design. ChemMedChem, 2008, 3, 690-713.
21. Arnal, A.A.; Buchholz, J.B.; Neidle, S.; Vilar, R. Effects of metal coordination geometry on stabilization of human telomeric quadruplex DNA by square-planar and square-pyramidal metal complexes. Inorg. Chem., 2008, 47, 11910-11919.
22. Tana, J.H.; Gu, L.Q.; Wub, J.Y. Design of selective G-quadruplex ligands as potential anticancer agents. Mini Rev. Med. Chem., 2008, 8, 1163-1178.
23. Arola, A.; Vilar, R. Stabilisation of G-quadruplex DNA by small molecules. Curr. Top. Med. Chem., 2008, 8, 1405-1415.
24. Franceschin, M. G-quadruplex DNA structures and organic chemistry: more than one connection. Eur. J. Org. Chem., 2009, 2225-2238.
25. Chen, B.; Liang, J.L.; Tian, X.P.; Liu, X.C. G-quadruplex structure: a target for anticancer therapy and a probe for detection of potassium. Biochemistry (Moscow), 2008, 73, 853-861.
26. Izbicka, E.; Wheelhouse, R.T.; Raymond, E.; Davidson, K.K.; Lawrence, R.A.; Sun, D.; Windle, B.E.; Hurley, L.H.; Von Hoff, D.D. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res., 1999, 59, 639-644.
27. Shi, D.F.; Wheelhouse, R.T.; Sun, D.; Hurley, L.H. Quadruplex interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J. Med. Chem., 2001, 44, 4509-4523.
28. Wheelhouse, R.T., Sun, D., Han, H., Han, F.X.; Hurley, L.H. Cationic porphyrins as telomerase inhibitors: the interaction of tetra-(N-methyl-4-pyridyl) porphine with quadruplex DNA. J. Am. Chem. Soc., 1998, 120, 3261-3262.
29. Hurley, L.H.; Wheelhouse, R.T.; Sun, D.; Kerwin, S.M.; Salazar, M.; Federoff, O.Y.; Han, F.X.; Han, H.; Izbicka, E.; Von Hoff, D.D. G-quadruplexes as targets for drug design. Pharmacol. Ther., 2000, 85, 141-158.
30. Ren, J.; Chaires, J.B. Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry, 1999, 38, 16067-16075.
31. Maraval, A.; Franco, S.; Vialas, C.; Pratviel, G.; Blasco, M.A.; Meunier, B. Porphyrin-aminoquinoline conjugates as telomerase inhibitors. Org. Biomol. Chem., 2003, 1, 921-927.
32. Prince, S.; Kçrber, F.; Cooke, P.R.; Lindsay Smith, J.R.; Mazid, M.A. Structure of monomeric hydrated manganese(III) tetra(4-N-methylpyridyl)porphyrin pentachloride. Acta Crystallogr., 1993, C49, 1158-1160.
33. Dixon, I.M.; Lopez, F.; Tejera, A.M.; Esteve, J.P.; Blasco, M.A.; Pratviel, G.; Meunier, B. A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. J. Am. Chem. Soc., 2007, 129, 1502-1503.
34. Keating L.R.; Szalai, V.A. Parallel-stranded guanine quadruplex interactions with a copper cationic porphyrin. Biochemistry, 2004, 43, 15891-15900.
35. Goncalves, D.P.; Rodriguez, R.; Balasubramanian, S.; Sanders, J.K. Tetramethylpyridiniumporphyrazines-a new class of G-quadruplex inducing and stabilising ligands. Chem. Commun., 2006, 4685-4687.
36. Ren, L.; Zhang, A.; Huang, J.; Wang, P.; Weng, X.; Zhang, L.; Liang, F.; Tan, Z.; Zhou, X. Quaternary ammonium zinc phthalocyanine: Inhibiting telomerase by stabilizing G-quadruplexes and inducing G-quadruplex structure transition and formation. ChemBioChem, 2007, 8, 775-780.
37. Gershman, Z.; Goldberg, I.; Gross, Z. DNA binding and catalytic properties of positively charged corroles. Angew. Chem. Int. Ed., 2007, 46, 4320-4324.
38. Fu, B.; Huang, J.; Ren, L.; Weng, X.; Zhou, Y.; Du, Y.; Wu, X.; Zhou X.; Yang, G. Cationic corrole derivatives: a new family of G-quadruplex inducing and stabilizing ligands. Chem. Commun., 2007, 3264-3266.
39. Fu, B.Q.; Zhang, D.; Weng, X.C.; Zhang, M.; Ma, H.; Y.Z. Ma, and Zhou, X. Cationic metal-corrole complexes: design, synthesis, and properties of guanine-quadruplex stabilizers. Chem. Eur. J., 2008, 14, 9431-9441.
40. Reed, J.E.; White, A.J.P.; Neidle, S.; Vilar, R. Effect of metal coordination on the interaction of substituted phenanthroline and pyridine ligands with quadruplex DNA. Dalton Trans., 2009, 2558-2568.
41. Schubert, U.S.; Hofmeier, H.; Newkome, G.R. Modern Terpyridine Chemistry, Wiley-VCH: Weinheim, 2006.
42. Constable, E.C. 2,29,69,20-Terpyridines: from chemical obscurity to common supramolecular motifs. Chem. Soc. Rev., 2007, 36, 246-253.
43. Ma, D.L.; Che, C.M.; Yan, S.C. Platinum(II) complexes with dipyridophenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA. J. Am. Chem. Soc., 2009, 131, 1835-1846.
44. Tuntiwechapikul, W.; Lee, J.T.; Salazar, M. Design and synthesis of the G-quadruplex-specific cleaving reagent perylene-EDTA. Iron (II). J. Am. Chem. Soc., 2001, 123, 5606-5607.
45. Sato, S.; Kondo, H.; Nojima, T.; Takenaka, S. Electrochemical telomerase assay with ferrocenylnaphthalene diimide as a tetraplex DNA-specific binder. Anal. Chem., 2005, 77, 7304-7309.
46. + solutions. Nucleic Acids Res., 2003, 31, 1605-1613.
47. Ourliac-Garnier, I.; Elizondo-Riojas, M.A.; Redon, S.; Farrell, N.P.; Bombard S. Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures. Biochemistry, 2005, 44, 10620-10634.
48. Ourliac-Garnier, I.; Bombard, S. GG sequence of DNA and the human telomeric sequence react with cis-diammine-diaquaplatinum at comparable rates. J. Inorg. Biochem., 2007, 101, 514-524.
49. Bertrand, H.; Bombard, S.; Monchaud, D.; Teulade-Fichou, M.P. New platinum(II) complexes targeting the loops of the human telomeric G-quadruplex. Nucleic Acids Symp. Ser., 2008, No. 52, 163-164.
50. Martins, E.T.; Baruah, H.; Kramarczyk, J.; Saluta, G.; Day, C.S.; Kucera, G.L.; Bierbach, U. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore. J. Med. Chem., 2001, 44, 4492-4496.
51. Ackley, M.C.; Barry, C.G.; Mounce, A.M.; Farmer, M.C.; Springer, B.E.; Day, C.S.; Wright, M.W.; Berners-Price, S.J.; Hess, S.M.; Bierbach, U. Structure-activity relationships in platinumacridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity. J. Biol. Inorg. Chem., 2004, 9, 453-461.
52. Hess, S.M.; Mounce, A.M.; Sequeira, R.C.; Augustus, T.M.; Ackley, M.C.; Bierbach, U. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin. Cancer Chemother. Pharmacol, 2005, 56, 337-343.
53. Hess, S.M.; Andersona, J.G.; Bierbachb, U. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells. Bioorg. Med. Chem. Lett., 2005, 15, 443-446.
54. Lu, R.; Bierbach, U. Kinetically favored platination of adenine in the G-rich human telomere repeat. J. Am. Chem. Soc., 2007, 129, 15764-15765.
55. Monchaud, D.; Yang, P.; Lacroix, L.; Teulade-Fichou, M.P.; Mergny, J.L. A metal-mediated conformational switch controls G-quadruplex binding affinity. Angew. Chem. Int. Ed., 2008, 47, 4858-4861.